Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly

PLoS Pathogens

Volumn 8, Issue 8, 2012, Pages

  Neveu, Gregory ^a   Barouch Bentov, Rina ^a   Ziv Av, Amotz ^a   Gerber, Doron ^b   Jacob, Yves ^c   Einav, Shirit ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CORE PROTEIN; PROTEIN SERINE THREONINE KINASE; TYROSINE; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE DISRUPTION; GENE EXPRESSION; GENETIC COMPLEMENTATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MICROFLUIDICS; NONHUMAN; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION;

ADAPTOR PROTEIN COMPLEX 2; AMINO ACID MOTIFS; CELL LINE; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RNA, VIRAL; TRANS-GOLGI NETWORK; VIRAL CORE PROTEINS; VIRUS ASSEMBLY;

HEPATITIS C VIRUS;

EID: 84866154404     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002845     Document Type: Article

References (104)

1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH, (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132: 296-305.
2. Soriano V, Vispo E, Poveda E, Labarga P, Martin Carbonero L, et al. (2011) Directly acting antivirals against hepatitis C virus. J Antimicrob Chemother 66: 1673-1686.
3. Bartenschlager R, Lohmann V, (2000) Replication of hepatitis C virus. J Gen Virol 81 Pt 7: 1631-1648.
4. Branch AD, (2000) Hepatitis C virus RNA codes for proteins and replicates: does it also trigger the interferon response? Semin Liver Dis 20: 57-68.
5. Reed KE, Rice CM, (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242: 55-84.
6. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
7. Roingeard P, Hourioux C, Blanchard E, Brand D, Ait Goughoulte M, (2004) Hepatitis C virus ultrastructure and morphogenesis. Biol Cell 96: 103-108.
8. Rouille Y, Helle F, Delgrange D, Roingeard P, Voisset C, et al. (2006) Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus. J Virol 80: 2832-2841.
9. Boson B, Granio O, Bartenschlager R, Cosset F-L, (2011) A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLoS Pathog 7: e1002144-e1002144.
10. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, et al. (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 1089-1097.
11. Boulant S, Targett-Adams P, McLauchlan J, (2007) Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88: 2204-2213.
12. Fukasawa M, (2010) Cellular lipid droplets and hepatitis C virus life cycle. Biol Pharm Bull 33: 355-359.
13. Shi S, Polyak S, Tu H, Taylor D, Gretch D, et al. (2002) Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292: 198-210.
14. Barba G, Harper F, Harada T, Kohara M, Goulinet S, et al. (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94: 1200-1205.
15. Moradpour D, Englert C, Wakita T, Wands JR, (1996) Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222: 51-63.
16. Mackenzie JM, Westaway EG, (2001) Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol 75: 10787-10799.
17. Mukhopadhyay S, Kuhn R, Rossmann M, (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13-22.
18. Roingeard P, Hourioux C, Blanchard E, Prensier G, (2008) Hepatitis C virus budding at lipid droplet-associated ER membrane visualized by 3D electron microscopy. Histochem Cell Biol 130: 561-566.
19. Jones D, McLauchlan J, (2010) Hepatitis C virus: assembly and release of virus particles. J Biol Chem 285: 22733-9.
20. Cocquerel L, Duvet S, Meunier JC, Pillez A, Cacan R, et al. (1999) The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. J Virol 73: 2641-2649.
21. Cocquerel L, Meunier JC, Pillez A, Wychowski C, Dubuisson J, (1998) A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72: 2183-2191.
22. Coller K, Heaton N, Berger K, Cooper J, Saunders J, et al. (2012) Molecular determinants and dynamics of hepatitis C virus secretion. PLoS Pathog 8: e1002466-e1002466.
23. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, et al. (2008) Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion. J Virol 82: 2120-2129.
24. Huang H, Sun F, Owen D, Li W, Chen Y, et al. (2007) Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104: 5848-5853.
25. Chang K-S, Jiang J, Cai Z, Luo G, (2007) Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture. J Virol 81: 13783-13793.
26. Jiang J, Luo G, (2009) Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol 83: 12680-12691.
27. Merz A, Long G, Hiet M-S, Brügger B, Chlanda P, et al. (2011) Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome. J Biol Chem 286: 3018-3032.
28. Bartenschlager R, Penin F, Lohmann V, Andre P, (2011) Assembly of infectious hepatitis C virus particles. Trends Microbiol 19: 95-103.
29. McLauchlan (2000) Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 7: 2-14.
30. McLauchlan J, Lemberg M, Hope G, Martoglio B, (2002) Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21: 3980-3988.
31. Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, et al. (2006) Structural Determinants That Target the Hepatitis C Virus Core Protein to Lipid Droplets. J Biol Chem 281: 22236-22247.
32. Boulant S, Vanbelle C, Ebel C, Penin Fo, Lavergne J-P, (2005) Hepatitis C Virus Core Protein Is a Dimeric Alpha-Helical Protein Exhibiting Membrane Protein Features. J Virol 79: 11353-11365.
33. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, et al. (2010) Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16: 1295-1298.
34. Parent R, Qu X, Petit M-A, Beretta L, (2009) The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology 49: 1798-1809.
35. Backes P, Quinkert D, Reiss S, Binder M, Zayas M, et al. (2010) Role of Annexin A2 in the Production of Infectious Hepatitis C Virus Particles. J Virol 84: 5775-5789.
36. Tamai K, Shiina M, Tanaka N, Nakano T, Yamamoto A, et al. (2012) Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. Virology 422: 377-385.
37. Ma Y, Yates J, Liang Y, Lemon SM, Yi M, (2008) NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly. J Virol 82: 7624-7639.
38. Steinmann E, Penin F, Kallis S, Patel A, Bartenschlager R, et al. (2007) Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 3: e103-e103.
39. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM, (2007) Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus. J Virol 81: 8374-8383.
40. Stapleford KA, Lindenbach BD, (2011) Hepatitis C Virus NS2 Coordinates Virus Particle Assembly through Physical Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes. J Virol 85: 1706-1717.
41. Jirasko V, Montserret R, Lee J, Gouttenoire J, Moradpour D, et al. (2010) Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog 6: e1001233-e1001233.
42. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, et al. (2008) Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles. J Virol 82: 7964-7976.
43. Tellinghuisen T, Foss K, Treadaway J, (2008) Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4: e1000032-e1000032.
44. Appel N, Zayas M, Miller S, Krijnse Locker J, Schaller T, et al. (2008) Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4: e1000035-e1000035.
45. Hughes M, Griffin S, Harris M, (2009) Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles. J Gen Virol 90: 1329-1334.
46. Counihan N, Rawlinson S, Lindenbach B, (2012) Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog 7: e1002302-e1002302.
47. Ohno H, (2006) Clathrin-associated adaptor protein complexes. J Cell Science 119: 3719-3721.
48. Nakatsu F, Ohno H, (2003) Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct 28: 419-429.
49. Owen D, Collins B, Evans P, (2004) Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Biol 20: 153-191.
50. Traub LM, Bannykh SI, Rodel JE, Aridor M, Balch WE, et al. (1996) AP-2-containing clathrin coats assemble on mature lysosomes. J Cell Biol 135: 1801-1814.
51. Ricotta D, Conner SD, Schmid SL, von Figura K, Honing S, (2002) Phosphorylation of the AP2 u subunit by AAK1 mediates high affinity binding to membrane protein sorting signals. J Cell Biol 156: 791-795.
52. Korolchuk VI, Banting G, (2002) CK2 and GAK/auxilin2 Are Major Protein Kinases in Clathrin-Coated Vesicles. Traffic 3: 428-439.
53. Zhang CX, Engqvist-Goldstein ÅEY, Carreno S, Owen DJ, Smythe E, et al. (2005) Multiple Roles for Cyclin G-Associated Kinase in Clathrin-Mediated Sorting Events. Traffic 6: 1103-1113.
54. Puffer BA, Watkins SC, Montelaro RC, (1998) Equine Infectious Anemia Virus Gag Polyprotein Late Domain Specifically Recruits Cellular AP-2 Adapter Protein Complexes during Virion Assembly. J Virol 72: 10218-10221.
55. Puffer BA, Parent LJ, Wills JW, Montelaro RC, (1997) Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 71: 6541-6546.
56. Chen C, Vincent O, Jin J, Weisz OA, Montelaro RC, (2005) Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J Biol Chem 280: 40474-40480.
57. Noble B, Abada P, Nunez-Iglesias J, Cannon PM, (2006) Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release. J Virol 80: 2924-2932.
58. Batonick M, Favre M, Boge M, Spearman P, Hning S, et al. (2005) Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology 342: 190-200.
59. Corless L, Crump CM, Griffin SDC, Harris M, (2010) Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. J Gen Virol 91: 362-372.
60. Ariumi Y, Kuroki M, Maki M, Ikeda M, Dansako H, et al. (2011) The ESCRT system is required for hepatitis C virus production. PLOS One 6: e14517-e14517.
61. Lai C-K, Jeng K-S, Machida K, Lai MMC, (2010) Hepatitis C Virus Egress and Release Depend on Endosomal Trafficking of Core Protein. J Virol 84: 11590-11598.
62. Aguilar RC, Boehm M, Gorshkova I, Crouch RJ, Tomita K, et al. (2001) Signal-binding Specificity of the mu4 Subunit of the Adaptor Protein Complex AP-4. J Biol Chem 276: 13145-13152.
63. Cusick ME, Klitgord N, Vidal M, Hill DE, (2005) Interactome: gateway into systems biology. Hum Mol Genet 14Spec No. 2:R171-8.
64. Bailer SM, Haas J, (2009) Connecting viral with cellular interactomes. Curr Opin Microbiol 12: 453-459.
65. Maerkl SJ, Quake SR, (2007) A systems approach to measuring the binding energy landscapes of transcription factors. Science 315: 233-237.
66. Einav S, Gerber D, Bryson PD, Sklan EH, Elazar M, et al. (2008) Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis. Nat Biotechnol 26: 1019-1027.
67. Gerber D, Maerkl SJ, Quake SR, (2009) An in vitro microfluidic approach to generating protein-interaction networks. Nat Methods 6: 71-74.
68. Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chnatier T, et al. (2011) Benchmarking a luciferase complementation assay for detecting protein complexes. Nat Methods 8: 990-992.
69. Gminard C, De Gassart A, Blanc L, Vidal M, (2004) Degradation of AP2 during reticulocyte maturation enhances binding of hsc70 and Alix to a common site on TFR for sorting into exosomes. Traffic 5: 181-193.
70. Lohmann V, Körner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
71. Wang Y-H, Chang S, Huang C, Li Y-P, Lee C-H, et al. (2005) Novel nuclear export signal-interacting protein, NESI, critical for the assembly of hepatitis delta virus. J Virol 79: 8113-8120.
72. Ricotta D, Hansen J, Preiss C, Teichert D, HÃning S, (2008) Characterization of a Protein Phosphatase 2A Holoenzyme That Dephosphorylates the Clathrin Adaptors AP-1 and AP-2. J Biol Chem 283: 5510-5517.
73. Murray CL, Jones CT, Tassello J, Rice CM, (2007) Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus. J Virol 81: 10220-10231.
74. Kopp M, Murray CL, Jones CT, Rice CM, (2010) Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein. J Virol 84: 1666-1673.
75. Ohno H, Aguilar RC, Yeh D, Taura D, Saito T, et al. (1998) The Medium Subunits of Adaptor Complexes Recognize Distinct but Overlapping Sets of Tyrosine-based Sorting Signals. J Biol Chem 273: 25915-25921.
76. Hitchcock IS, Chen MM, King JR, Kaushansky K, (2008) YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation. Blood 112: 2222-2231.
77. Dunn KW, Kamocka MM, McDonald JH, (2011) A practical guide to evaluating colocalization in biological microscopy. Am J of Physiol- Cell Physiol 300: C723-C742.
78. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132.
79. Hourioux C, Ait Goughoulte M, Patient R, Fouquenet D, Arcanger Doudet F, et al. (2007) Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell microbiol 9: 1014-1027.
80. Toh Q, Tan T, Teo W, Ho C, Parida S, et al. (2005) Identification of cellular membrane proteins interacting with hepatitis B surface antigen using yeast split-ubiquitin system. Int J Med Sci 2: 114-117.
81. Rost M, Mann S, Lambert C, Doring T, Thome N, et al. (2006) Gamma2-Adaptin, a Novel Ubiquitin-interacting Adaptor, and Nedd4 Ubiquitin Ligase Control Hepatitis B Virus Maturation. J Biol Chem 281: 29297-29308.
82. Hartmann-Stahler C, Prange R, (2001) Hepatitis B Virus Large Envelope Protein Interacts with γ2-Adaptin, a Clathrin Adaptor-Related Protein. J Virol 75: 5343-5351.
83. Freed EO, (2002) Viral Late Domains. J Virol 76: 4679-4687.
84. Zhou H, Wang F, Wang Y, Ning Z, Hou W, et al. (2011) Improved Recovery and Identification of Membrane Proteins from Rat Hepatic Cells using a Centrifugal Proteomic Reactor. Mol Cell Proteomics 10: O111.008425.
85. Eden ER, White IJ, Tsapara A, Futter CE, (2010) Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction. Nat Cell Biol 12: 267-272.
86. Liu P, Bartz R, Zehmer J, Ying Y-s, Zhu M, et al. (2007) Rab-regulated interaction of early endosomes with lipid droplets. Biochim Biophys Acta 1773: 784-793.
87. Dong X, Li H, Derdowski A, Ding L, Burnett A, et al. (2005) AP-3 Directs the Intracellular Trafficking of HIV-1 Gag and Plays a Key Role in Particle Assembly. Cell 120: 663-674.
88. Barouch Bentov R, Sauer K, (2011) Mechanisms of drug resistance in kinases. Expert Opin Investig Drugs 20: 153-208.
89. Knight ZA, Shokat KM, (2005) Features of Selective Kinase Inhibitors. Chem Biol 12: 621-637.
90. Lupberger J, Zeisel M, Xiao F, Thumann C, Fofana I, et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17: 589-595.
91. Bardou Jacquet E, Lorho R, Guyader D, (2012) Kinase inhibitors in the treatment of chronic hepatitis C virus. Gut 60: 879-880.
92. Gottwein JM, Scheel TKH, Jensen TB, Ghanem L, Bukh J, (2011) Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses. Gastroenterology 141: 1067-1079.
93. Fischer T, Stone RM, DeAngelo DJ, Galinsky I, Estey E, et al. (2010) Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3. J Clin Onc 28: 4339-4345.
94. Rock EP, Goodman V, Jiang JX, Mahjoob K, Verbois SL, et al. (2007) Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell Carcinoma. Oncologist 12: 107-113.
95. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, et al. (2005) Erlotinib in Previously Treated Non Small-Cell Lung Cancer. N Engl J Med 353: 123-132.
96. Kelley R, Ko A, (2008) Erlotinib in the treatment of advanced pancreatic cancer. Biologics 2: 83-95.
97. Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, et al. (2006) Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol 8: 67-78.
98. Jilg N, Chung RT, (2012) Adding to the toolbox: Receptor tyrosine kinases as potential targets in the treatment of hepatitis C. J Hepatol 56: 282-284.
99. Schwartz M, Chen J, Janda M, Sullivan M, den Boon J, et al. (2002) A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. Mol Cell 9: 505-514.
100. Remy I, Michnick SW, (2007) Application of protein-fragment complementation assays in cell biology. Biotechniques 42: 137-145.
101. Rual J-F, Hirozane-Kishikawa T, Hao T, Bertin N, Li S, et al. (2004) Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 14: 2128-2135.
102. Blight KJ, Kolykhalov AA, Rice CM, (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972-1974.
103. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80: 1734-1741.
104. Einav S, Elazar M, Danieli T, Glenn JS, (2004) A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication. J Virol 78: 11288-11295.